Skip to content

Clinical trials

Phase 2 Leukemia, Myeloid, Acute trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2 Country / region: Netherlands Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20092
20101
20111
20131
20142
20151
20162
20181
20191
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Celgene2
Novartis Pharmaceuticals2
Radboud University Medical Center2
Chroma Therapeutics1
Cogent Biosciences, Inc.1
Daiichi Sankyo1
GWT-TUD GmbH1
Karyopharm Therapeutics Inc1
Millennium Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute19
Leukemia8
Myelodysplastic Syndromes4
Recurrence3
Hematologic Diseases2
Hematologic Neoplasms2
Leukemia, Erythroblastic, Acute2
Leukemia, Megakaryoblastic, Acute2
Leukemia, Monocytic, Acute2
Leukemia, Myelomonocytic, Acute2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.